Susan Hasty, Publisher
Table of Contents . . . February 16th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Anti-Infectives Week | Other Publications
Anti-Infectives - Sponge sterol reverses Candida fluconazole resistance
Antibiotics - Little evidence shown that antibiotic used in food animals is a risk to humans
Antibiotics - New methods for overexpression and purification of phosphorylases developed
Antibiotics - Novel oxazolidinone more potent than linezolid against aerobic isolates
Bacterial Sinusitis - Guidelines underscore importance of selecting the most effective antibiotics
Collaborations - Alliance formed for medicinal chemistry development
Collaborations - Medarex inks antibody deal
Cystic Fibrosis - Antibiotic exposure not the only cause of antibiotic resistance
Drug Development - Amaryllidaceae extracts have potent antimalarial activity
Drug Development - Company meets with FDA on MBI-226
Drug Development - Fungal metabolite inhibits HIV integrase activity
Antimicrobials - Protein with antimicrobial activity from frog skin identified as histone H2B
Drug Development - Mirror-image Zintevir analogue has similar anti-HIV activity
Drug Development - Novel CCR5 antagonists show promise and anti-HIV agents
Drug Development - Novel NNRTIs prevent HIV infection in vitro
Drug Development - Plant jasmonates have antiparasitic as well as anticancer activity
Finance - Developmental stage biopharmaceutical completes private placement
HIV/AIDS Drug Monitoring - LC/MS/MS assay enables ddI, d4T monitoring in wide range of specimen types
HIV/AIDS Drug Resistance - Role of secondary mutations in protease inhibitor resistance evaluated
HIV/AIDS Lipodystrophy - Heightened cytokine activity involved in pathogenesis
HIV/AIDS Opportunistic Infection - Mechanisms of Hst 5 candidacidal activity clarified
HIV/AIDS Opportunistic Infection - Risk of drug-resistant P. aeruginosa reduced in HAART era
Antibiotics - Analysis of antibiotics by capillary electrophoresis reviewed
HIV/AIDS RNA Research - Pseudoknots are key feature of RNA aptamers that bind HIV NC protein
HIV/AIDS Therapy - Amprenavir prodrug safe and effective, with reduced pill burden
HIV/AIDS Therapy - Enzyme immunoassay enables intracellular nevirapine measurment
HIV/AIDS Therapy - Once-daily lamivudine 300 mg equivalent to 150 mg BID
HIV/AIDS Therapy - Tenofovir DF pharmacokinetics similar in children and adults
Hemophilia - Treatment for HIV and HCV infections in hemophiliacs reviewed
Infectious Disease - Meningococcal penicillin G breakpoints identified
Influenza - Researchers add new drug prophylactic option against flu
Malaria Therapy - A. annua multi-harvesting improves artemisinin yield
Malaria Therapy - Alkaloid mixture enhances chloroquine efficacy in mice
Drug Resistance - Mutagenesis of SugE, a small multidrug resistance protein, investigated
Malaria Therapy - Novel LC assay accurately measures AQ and AQm in whole blood
Mosquito-borne Disease - Efficacy of pyrethroid-organophosphorous-treated bednets evaluated
Neuroscience - Maternal infections during pregnancy may encourage schizophrenia in offspring
Recombinant Research - Solubility partner for recombinant expression of streptavidin developed
Stem-Cell Transplantation - After treatment, SCT is feasible in patients with fungal infections
Tuberculosis Therapy - Isoniazid inhibits mycobacterial beta-ketoacyl reduction
Tuberculosis Therapy - Post-antibiotic effects of anti-TB agents evaluated
Wound Care - INDERMIL Tissue Adhesive receives FDA approval as a microbial barrier
Acne - XMP.629 peptide acne treatment advances into phase II clinical trial
Acute Bacterial Sinusitis - FDA approves Zithromax as treatment for acute bacterial sinusitis
Antibiotic Production - Use of fermentation route to make beta-lactams could offer huge cost savings
Antibiotic Resistance - Study links ear drops with an increase in resistant bacteria
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.